Stock Taper
SCREENER COMPARE ANY 2 STOCKS
KTTAW
PASITHEA THERAPEUTICS CORP.
NASDAQ
$0.01
▲ UP 174.07% (0.00)

KEY STATISTICS

Market Cap$55.07 K
52w High$0.01
52w Low$0.00
Dividend Yield—
Frequency—
P/E—
Volume10.90K
Shares Out.7.44M

COMPANY

LEADERSHIP

Tiago Reis Marques
CHIEF EXECUTIVE
Tiago Reis Marques

COMPENSATION 2026

Salary$450,000
Stock Awards$22,241
Incentive Plan Pay$0
All Other Comp.$0
Total$640,059

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 15, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
5

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.—
DEC
2
WED

PRICE

$0.01 ▲ UP 174.07% (+$0.00)
$0.00$0.01$0.0110:04 AM10:22 AM10:40 AM10:58 AM11:15 AM11:33 AM11:51 AM0.01

About Pasithea Therapeutics Corp.

https://www.pasithea.com ↗

Pasithea Therapeutics Corp., founded in 2020 in Miami Beach, Florida, researches psychiatric and neurological treatments, plans anti-depression clinics, and offers infusion services with trained pharmacists for ketamine therapy.

INDUSTRY

Biotechnology

A PRODUCT PASITHEA THERAPEUTICS CORP. IS KNOWN FOR

PAS-004
PAS-004

PAS-004 is a next-generation, oral MEK inhibitor currently in Phase 1/1b clinical trials. [8] It is Pasithea Therapeutics' lead drug candidate for treating a range of RASopathies and cancers, including neurofibromatosis type 1 (NF1). [6, 7]

COMPETITORS

COMPETITOR
CNSP COMPARE
ELVN COMPARE
GNTA COMPARE
PRLD COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
6.65%
HOLDERS
8
TOP 8 OF 8 · RANKED BY POSITION SIZE
Kepos Capital LP
334.6K sh · $5K
Two Sigma Securities, LLC
55.6K sh · $784
Armistice Capital, LLC
50.0K sh · $705
Marex Group Plc
25.0K sh · $345
Citadel Advisors LLC
15.2K sh · $207
Susquehanna International Group, Llp
14.6K sh · $247
Clear Street LLC
71 sh · $2
Concourse Financial Group Securities, Inc.
0 sh · $0

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

★
10 PERCENT OWNER
Coastlands Capital LP
Purchase · 100.0K shares
2026-06-17
★
DIRECTOR
Leahy Emer
Purchase · 152.8K shares
2026-05-01
★
DIRECTOR
STEINMAN LAWRENCE
Purchase · 152.8K shares
2026-05-01
★
OFFICER
Krishnan Kartik
— · —
2026-05-01

SECTORS PEERS

PEERPRICE
AKTX$11.29COMPARE
REVB$1.01COMPARE
DRMA$1.21COMPARE
NKGN$0.00COMPARE
SYRS$0.00COMPARE
SLXNW$0.01COMPARE
MSPR$0.00COMPARE
VRPX$0.00COMPARE